Pediatrics Strabismus News

Cataract surgery in infants is associated with a high risk of secondary glaucoma, especially in eyes with associated microphthalmia, microcornea or persistent fetal vasculature, according to a study.

After viral causes, bacteria are the next most common cause of infectious conjunctivitis. Relatively short courses of treatment can resolve bacterial conjunctivitis, whereas chronic or seasonal allergic conjunctivitis requires longer therapy.

In this guest editorial, David Brottman, MD, FAAP, a recently retired pediatrician in Arlington, Illinois, discusses device-based vision screening strategies for children, and how new technology can improve outcomes in the primary care setting.

Incorporating well-trained pediatric optometrists into pediatric ophthalmology practices has helped expand primary pediatric eye care services to children, often closing gaps in access to this often routine but nonetheless important service.

In the first phase of the ongoing four-phase LAMP study, researchers report 0.05% atropine was most effective among three concentrations and placebo in controlling spherical equivalent and axial length in children with myopia.

Subconcussive head impacts negatively affect near point of convergence; however, over time, the oculomotor system could adapt to subclinical brain injuries, according to a study.

The Scottish Medicines Consortium has approved Verkazia eye drop emulsion for the treatment of vernal keratoconjunctivitis in children from 4 years of age and adolescents, Santen UK Limited announced in a press release.

In October, the American Academy of Ophthalmology held its annual meeting in Chicago, featuring presentations on the latest advancements in the specialty.

Pediatric patients with open and closed globe injuries experienced good visual acuity improvement after undergoing sutured scleral-fixated IOL implantation.

Postnatal weight gain may be a valid parameter to stratify infants at risk for developing retinopathy of prematurity, according to a study. More specifically, a weight gain of at least 23 g/day can be considered as a protective cut-off value against development of ROP.